The Vitaliano B. Bernardino Jr., MD Visiting Professorship in Pathology Melike Pekmezci, MD [NON-CME]

Click here to register for the livestream

In this series, we welcome influential ophthalmologists from around the country and the world to speak at Wills Eye Hospital for the benefit of residents and practicing ophthalmologists. Presentations and lectures include clinical and non-clinical content, and reflections on each guest's professional journey. 

Dr. Melike Pekmezci is a Professor of Pathology and Ophthalmology at the University of California, San Francisco, with subspecialty expertise in neuropathology, ophthalmic pathology, and molecular pathology. She earned her medical degree from Hacettepe University in Turkey and completed two years of ophthalmology training there before moving to the United States. She subsequently completed her anatomic pathology residency, as well as fellowships in neuropathology and surgical pathology, at UCSF, where she later joined the faculty.

Dr. Pekmezci has authored or co-authored more than 150 publications. Her research is primarily translational, focusing on the identification of diagnostic and prognostic markers in central nervous system and ocular neoplasms. She is a co-editor of the third edition of Diagnostic Pathology: Neuropathology and has authored multiple book chapters, including contributions to the World Health Organization classifications of CNS tumors, soft tissue tumors, pediatric neoplasms, and ocular tumors. She is an active member of several professional organizations and has served on multiple committees within the American Association of Neuropathologists, the United States and Canadian Academy of Pathology (USCAP), the Society for Neuro-Oncology, and the American Association of Ocular Oncologists and Pathologists. She also serves on the editorial boards of the Journal of Neuropathology & Experimental Neurology and Brain Pathology, and has delivered numerous invited lectures and microscopic slide sessions at regional, national, and international meetings.

This series is not certified for CME credit. 

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.